← Leaderboards
Tianjing Li
Johns Hopkins University
$8,230,613
Attributed
$8,230,613
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,080,613 · 1
AHRQ$150,000 · 2
By mechanism
UG1$8,080,613 · 1
R03$100,000 · 1
R13$50,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Jeffrey T. Leek$8,596,644
- Ava Marie Hoffman$2,705,821
- Jeremy Goecks$11,144,983
- Martin Lindquist$16,701,900
- Ciprian M Crainiceanu$10,135,753
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventVisionCollaborationsInnovationDiagnosisHealth ProfessionalInternationalMassive Open Online CoursesFlexibilityGuidelinesAchievementHealthcareJournalsHealth TrainingEducational WorkshopAcademic Medical CentersCommunitiesEducationEvidence Based GuidelinesEvidence BaseCaringClinical PracticeClinical Practice GuidelineEnsure
Grant awards (12)
Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US Project$845,293
UG1 · FY2025 · EY · contact PI
Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US Project$994,462
UG1 · FY2024 · EY · contact PI
Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US Project$997,486
UG1 · FY2023 · EY · contact PI
Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US Project$999,563
UG1 · FY2022 · EY · contact PI
Comparative Effectiveness Research & Cochrane Eyes and Vision (CEV)$998,323
UG1 · FY2021 · EY · contact PI
Comparative Effectiveness Research & Cochrane Eyes and Vision (CEV)$249,361
UG1 · FY2021 · EY · contact PI
Comparative Effectiveness Research & Cochrane Eyes and Vision (CEV)$998,323
UG1 · FY2020 · EY · contact PI
Methods Symposium: Advanced Methods and Innovative Technologies for Evidence Synthesis$50,000
R13 · FY2020 · HS · contact PI
Comparative Effectiveness Research & Cochrane Eyes and Vision (CEV)$715,679
UG1 · FY2019 · EY · contact PI
Comparative Effectiveness Research & Cochrane Eyes and Vision (CEV)$282,644
UG1 · FY2019 · EY · contact PI
Comparative Effectiveness Research & Cochrane Eyes and Vision (CEV)$999,479
UG1 · FY2018 · EY · contact PI
Methods to Accelerate Network Meta-Analysis Production$100,000
R03 · FY2016 · HS · contact PI